Complete Remission in a TEMPI Syndrome Treated with a Daratumumab, Lenalidomide, and Dexamethasone-Based Regimen: A Case Report

Introduction: TEMPI syndrome is a rare and acquired condition which is characterized by five classical features: telangiectasias, erythrocytosis with elevated erythropoietin, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting. The classical treatment is based on bortez...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Pierre-Yves Sansen, Luc Montfort, Anne Nanquette, Julien Depaus, Hélène Vellemans
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Karger Publishers 2024-01-01
Edice:	Case Reports in Oncology
Témata:	tempi syndrome lenalidomide daratumumab mgrs case report
On-line přístup:	https://beta.karger.com/Article/FullText/535551
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!